GLP-X3 40mg
GHH Pharma Grade
The Next-Generation Triple Metabolic Stack

GLP-X3 40mg

High-dose GLP-X3 — maximum GLP-1 activity for significant weight loss

AED 2,849.00
Physician Required

GLP-X3 is a proprietary GHH triple peptide formulation combining the synergistic actions of three complementary metabolic peptides targeting multiple pathways simultaneously. Designed for patients who need maximum metabolic impact — particularly those with significant obesity, metabolic syndrome, or insufficient response to single-agent GLP-1 therapy — GLP-X3 represents the cutting edge of pharmaceutical-grade peptide weight management.

💉
Injectable / Oral
Administration
⏱️
2–4 weeks
First Results
🔄
12–24 month medical course
Cycle Length
🎯

Clinical Uses

What conditions & goals this peptide addresses

Severe metabolic syndrome
Multi-pathway weight loss
Visceral and subcutaneous fat reduction
Insulin resistance correction
Appetite dysregulation
Post-bariatric weight regain
✨

Key Benefits

The measurable outcomes you can expect

Multi-receptor activation for superior outcomes
Targets three distinct metabolic pathways
Enhanced satiety vs single-agent therapy
Superior visceral fat reduction
Improved glycaemic control
GHH physician-supervised personalised protocol
🔬

How It Works — Mechanism of Action

The precise biology behind this peptide's effects

GLP-X3 combines GLP-1, GIP, and glucagon pathway activation in a synergistic triple-receptor approach. The combination activates complementary satiety centres, fat mobilisation signals, and thermogenic pathways simultaneously — producing effects that exceed any single-receptor agonist through additive and synergistic action across the hypothalamic-metabolic axis.

Administration Guide

Weekly subcutaneous injection under physician supervision. Strict dose titration protocol required. Monthly lab monitoring by GHH clinical team.

💊

Dosage Protocol

GHH physician-guided dosing guidelines

Individualised GHH physician protocol. Titration starts at lowest dose and increases based on monthly metabolic response and tolerability. Contact GHH for consultation.

🔄
Cycle Length
12–24 month medical course
🧊
Storage
Refrigerate 2–8°C. Protect from light and heat. Do not freeze.
⏳

When to Expect Results

A realistic timeline from first dose to full effect

Appetite reduction: 2–4 weeks. Weight loss: Month 1–3 (significant). Full metabolic optimisation: Month 6–12.

Day 1–7
Week 2–4
Week 4–8
Week 8–16
⚠️

Side Effects

What to watch for and how common they are

GI effects (nausea, vomiting) dose-dependent. Injection site reactions. Blood glucose monitoring essential.

🚫

Contraindications

Who should not use this peptide

Thyroid carcinoma/MEN2 history. Pancreatitis. Active cancer. Pregnancy.

⚡

Best Stacked With

Peptide synergies recommended by GHH physicians

NAD+ for mitochondrial metabolic support BPC-157 for GI side effect management MOTS-C for AMPK-mediated fat oxidation

Compare this peptide side-by-side

See how it stacks up against other protocols

🩺

Ready to Start Your GLP-X3 Protocol?

All peptide protocols require a physician consultation and blood work. Our licensed UAE physicians will craft a personalised plan for you.

The Science of Peptides

Understanding Your Body's Language

Peptides are not exotic foreign chemicals — they are the precise molecular signals your body has evolved to use for billions of years. Here's what you need to know.

🔭
"Peptides don't change who you are — they restore who you were designed to be."

— German Health Hub Clinical Philosophy

All peptides require UAE licensed physician review and mandatory blood work before dispensing. Information presented is for educational purposes only and does not constitute medical advice. Individual results may vary. Peptides are prescribed and dispensed under strict medical supervision by German Health Hub's licensed clinical team.